D47.02 - Systemic mastocytosis

  • Applicable to Systemic mastocytosis
  • The 2025 edition of ICD10-CM D47.02 became effective on October 1, 2024.
  • This is the American ICD10-CM version of D47.02 - other international versions of ICD10 D47.02 may differ.
  • D47.02 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

 Inclusion Term

  • Indolent systemic mastocytosis
  • Isolated bone marrow mastocytosis
  • Smoldering systemic mastocytosis
  • Systemic mastocytosis, with an associated hematological non-mast cell lineage disease (SM-AHNMD)

Type 1 Excludes

  • aggressive systemic mastocytosis (C96.21)
  • mast cell leukemia (C94.3-)

codeAlso

  • , if applicable, any associated hematological non-mast cell lineage disease, such as:
  • acute myeloid leukemia (C92.6-, C92.A-)
  • chronic myelomonocytic leukemia (C93.1-)
  • essential thrombocytosis (D47.3)
  • hypereosinophilic syndrome (D72.1)
  • myelodysplastic syndrome (D46.9)
  • myeloproliferative syndrome (D47.1)
  • non-Hodgkin lymphoma (C82-C85)
  • plasma cell myeloma (C90.0-)
  • polycythemia vera (D45)

The following codes above D47.02 contain annotation back-references that may be applicable to D47.02:

Chapter: C00-D49 Neoplasms

Section: D37-D48 Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes

Category: D47 Other neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue

         
Billable/Specific Code

Browse other similar CM codes

             

Please, give attribution to our website icd-10code.com